<DOC>
	<DOC>NCT00344175</DOC>
	<brief_summary>This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304.</brief_summary>
	<brief_title>Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors</brief_title>
	<detailed_description>This is a sixteen-week, double-blind, active controlled, follow-on and 28 week single blind extension study for patients who participated in NK-104-304.</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Completed NK104304 (NCT 00309738) Hypercholesterolemia or combined dyslipidemia 2 or more risk factors for coronary heart disease (CHD) Withdrawn or terminated from NK104304 (00309738)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>hypercholesterolemia</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>CHD</keyword>
	<keyword>pitavastatin</keyword>
	<keyword>simvastatin</keyword>
	<keyword>2 or more risk factors for coronary heart disease</keyword>
	<keyword>combined dyslipidemia</keyword>
</DOC>